Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02980393
Other study ID # 102392
Secondary ID 18843
Status Completed
Phase N/A
First received November 24, 2016
Last updated December 20, 2016
Start date May 2012
Est. completion date November 2016

Study information

Verified date December 2016
Source Western University, Canada
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

This study is to assess whether a lifestyle intervention with diet, exercise and counselling in young patients will have a positive influence on their weight and overall well-being. This study will enrol patients between the ages of 7 to 17 years of age, who have congenital heart disease, and have been identified being overweight or obese. A total of 40 individuals will participate in this study. The study duration will last for 1 year.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date November 2016
Est. primary completion date November 2016
Accepts healthy volunteers No
Gender Both
Age group 7 Years to 17 Years
Eligibility Inclusion Criteria:

- overweight or obese (BMI> 85%) patients

- between 7-17 years of age

- operated or non-operated congenital heart disease

- reside in Southwestern Ontario

Exclusion Criteria:

- inability to comply with research testing or intervention components due to mental and/or physical disabilities, medications or comorbidities affecting weight or metabolic condition

- involvement in any concurrent lifestyle intervention program

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Intervention

Behavioral:
Lifestyle intervention
The structured lifestyle intervention involves alternating weekly phone calls with two health coaches: a registered dietitian and a fitness specialist. A total of 50 phone calls (25 nutrition-related and 25 physical activity-related) are delivered over the one-year study. After six months in the program, participants are introduced to supporting program-specific software that they can access online, as an additional way to interact with the program, set goals, and record their progress. Client and family-centred nutrition and physical activity counselling includes an initial and regular behavioural assessment, and subsequent conversations (i.e., phone calls) using motivational interviewing techniques intended to increase knowledge or skills, and improve behaviours.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Kambiz Norozi London Health Sciences Centre

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Baseline Body Mass Index (BMI) at 1 year BMI is derived from body mass divided by the square of the body height This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Primary Change in Baseline Fat Mass at 1 year Dual energy x-ray absorptiometry (DEXA) will measure fat mass. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Primary Change in Baseline Lean Mass at 1 year Dual energy x-ray absorptiometry (DEXA) will measure lean mass. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Primary Change in Baseline Percent Fat at 1 year Dual energy x-ray absorptiometry (DEXA) will measure percent fat. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Primary Change in Baseline Percent Android Fat at 1 year Dual energy x-ray absorptiometry (DEXA) will measure percent android fat. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Primary Change in Baseline Visceral Adipose Tissue at 1 year Dual energy x-ray absorptiometry (DEXA) will measure visceral adipose tissue. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Primary Change in Baseline Bone Mineral Content at 1 year Dual energy x-ray absorptiometry (DEXA) will measure bone mineral content. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Primary Change in Baseline Maximum Oxygen Consumption at 1 year Maximal exercise graded treadmill test will determine maximal oxygen consumption. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Average Caloric Intake at 1 year Average caloric intake is estimated from three-day food records. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Self-Report Physical Activity Levels at 1 year Physical activity levels will also be measured by the Physical Activity Questionnaire for Older Children This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Physical Activity Levels at 1 year Physical activity levels will be measured from accelerometers This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Quality of Life at 1 year Pediatric Quality of Life Inventory Generic Core Scales This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Muscle function at 1 year Leonardo Mechanograph® Ground Reaction Force Plate will assess jumping height. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Electrocardiographic measurement at 1 year Electrocardiogram This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Transthoracic echocardiographic measurement at 1 year Echo-cardiogram will be employed. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Endothelial vasodilator function at 1 year Peripheral arterial tonometry will assess endothelial vasodilator function. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Lipid Profile at 1 year Blood is drawn from patients who have been asked to fast for at least 10 hours. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Electrolytes at 1 year Blood is drawn from patients who have been asked to fast for at least 10 hours. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Creatinine at 1 year Blood is drawn from patients who have been asked to fast for at least 10 hours. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Urea at 1 year Blood is drawn from patients who have been asked to fast for at least 10 hours. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Fasting Glucose at 1 year Blood is drawn from patients who have been asked to fast for at least 10 hours. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Serum Insulin at 1 year Blood is drawn from patients who have been asked to fast for at least 10 hours. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
Secondary Change in Baseline Adiponectin at 1 year Blood is drawn from patients who have been asked to fast for at least 10 hours. This outcome was measured at Baseline, 6 months, 1 year within the 1 year time frame No
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04992793 - Paediatric Brain Injury Following Cardiac Interventions
Recruiting NCT05213598 - Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Completed NCT04136379 - Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD
Completed NCT04814888 - 3D Airway Model for Pediatric Patients
Recruiting NCT04920643 - High-exchange ULTrafiltration to Enhance Recovery After Pediatric Cardiac Surgery N/A
Completed NCT05934578 - Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training N/A
Recruiting NCT06041685 - Effect of Local Warming for Arterial Catheterization in Pediatric Anesthesia N/A
Recruiting NCT05902013 - Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation N/A
Not yet recruiting NCT05687292 - Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery
Not yet recruiting NCT05524324 - Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT N/A
Completed NCT02746029 - Cardiac Murmurs in Children: Predictive Value of Cardiac Markers
Completed NCT02537392 - Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease N/A
Completed NCT03119090 - Fontan Imaging Biomarkers (FIB) Study
Recruiting NCT02258724 - Swiss National Registry of Grown up Congenital Heart Disease Patients
Terminated NCT02046135 - Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery Phase 2
Completed NCT01966237 - Milrinone Pharmacokinetics and Acute Kidney Injury
Recruiting NCT01184404 - Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery N/A
Completed NCT01548950 - Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension N/A
Completed NCT01178710 - Effect of Simvastatin on Cardiac Function N/A